Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.

JAMA - 17 Jun 2009

Segal Jodi B, Brotman Daniel J, Necochea Alejandro J, Emadi Ashkan, Samal Lipika, Wilson Lisa M, Crim Matthew T, Bass Eric B

Abstract excerpt

CONTEXT: Testing for genetic risks for venous thromboembolism (VTE) is common, but the safety and utility of such testing need review. OBJECTIVES: To define rates of recurrent VTE among adults with VTE with a factor V Leiden (FVL) or prothrombin G20210A mutation compared with those without such mutations; to define rates of VTE among family members of adults with a FVL or prothrombin G20210A mutation according to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Factor V
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Predictive Value of Tests

Share to Prothrombin

Share to Risk Factors

Share to Venous Thromboembolism

Source

Identifiers

PMID: 19531787
DOI: 10.1001/jama.2009.853

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.PMID 19531787Read ↗

Outcomes of genetic testing in adults with a history of venous thromboembolism.Semantic proximity Read ↗

Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.Semantic proximity Read ↗

Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relativesSemantic proximity Read ↗

Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.Semantic proximity Read ↗

The Association of Prothrombin Gene G20210A Mutation with Recurrent Venous Thromboembolism: Evidence from a Meta-Analysis.Semantic proximity Read ↗

Genetic Testing for Thrombophilia-Related Genes: Observations of Testing Patterns for Factor V Leiden (G1691A) and Prothrombin Gene “Mutation” (G20210A)Semantic proximity Read ↗

Management of inherited thrombophilia: guide for genetics professionals.Semantic proximity Read ↗

Clinical and laboratory management of the prothrombin G20210A mutation.Semantic proximity Read ↗

Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis.Semantic proximity Read ↗

G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism.Semantic proximity Read ↗

Diagnosis and management offactor V LeidenSemantic proximity Read ↗

Factor V Leiden thrombophilia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.